Which statement about aspirin use in EMS during suspected myocardial infarction is true?

Which statement about aspirin use in EMS during suspected myocardial infarction is true?

• A. It dissolves existing clots instantly.
• B. It reduces pain by acting as an opioid.
• C. It increases platelet aggregation.
• D. It inhibits platelet aggregation to prevent further clot formation.

Answer: (D)

The key concept is aspirin’s role as an antiplatelet in suspected myocardial infarction. In this situation, the goal is to prevent further clot growth and propagation in the coronary arteries. Aspirin achieves this by irreversibly inhibiting the enzyme COX-1 in platelets, which stops the production of thromboxane A2, a substance that promotes platelet clumping and vasoconstriction. Because platelets have no nucleus, they can’t quickly replace COX-1, so the antiplatelet effect lasts for the life of the platelet (about a week). This is why the statement that aspirin inhibits platelet aggregation to prevent further clot formation is the true one. It is not dissolving clots instantly—that would be the role of thrombolytics. It isn’t acting as an opioid for pain relief, and it does not increase platelet aggregation; it reduces it. In EMS practice, aspirin is given to suspected MI patients who can safely take it (often a chewable 162–325 mg dose unless contraindicated) to help reduce mortality by limiting clot growth.

The key concept is aspirin’s role as an antiplatelet in suspected myocardial infarction. In this situation, the goal is to prevent further clot growth and propagation in the coronary arteries. Aspirin achieves this by irreversibly inhibiting the enzyme COX-1 in platelets, which stops the production of thromboxane A2, a substance that promotes platelet clumping and vasoconstriction. Because platelets have no nucleus, they can’t quickly replace COX-1, so the antiplatelet effect lasts for the life of the platelet (about a week).

This is why the statement that aspirin inhibits platelet aggregation to prevent further clot formation is the true one. It is not dissolving clots instantly—that would be the role of thrombolytics. It isn’t acting as an opioid for pain relief, and it does not increase platelet aggregation; it reduces it.

In EMS practice, aspirin is given to suspected MI patients who can safely take it (often a chewable 162–325 mg dose unless contraindicated) to help reduce mortality by limiting clot growth.